Please login to the form below

Not currently logged in
Email:
Password:

baloxavir marboxil

This page shows the latest baloxavir marboxil news and features for those working in and with pharma, biotech and healthcare.

Roche’s new flu pill Xofluza approved in US

Roche’s new flu pill Xofluza approved in US

The FDA has approved Roche’s new flu treatment Xofluza (baloxavir marboxil), the first new antiviral drug in nearly 20 years.

Latest news

  • Encouraging data for Roche flu drug ahead of FDA decision Encouraging data for Roche flu drug ahead of FDA decision

    complications. Baloxavir marboxil is a single-dose, investigational oral medicine, and has just achieved its primary endpoint in the CAPSTONE-2 trial comparing it with placebo and Tamiflu. ... If approved, baloxavir marboxil will be the first single-dose

  • Roche’s Tamiflu successor hits the mark in complicated flu Roche’s Tamiflu successor hits the mark in complicated flu

    Baloxavir marboxil met its primary objective and cut flu-related complications. Roche has reported a second pivotal data on a novel influenza drug – baloxavir marboxil – that it says is the first ... With baloxavir marboxil Roche now looks like it

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics